Thank you, Mr. Chairman.
Thanks very much to our presenters.
We've been hearing a fair amount of testimony on this topic for quite a few meetings now, and there seems to be a common theme coming through, whether or not you agree that the CDR is doing a good job or not, and there's certainly two points of view on that. There is a common theme that a review is necessary.
I have a couple of very basic questions that I want to throw out here. I don't know who wants to answer them.
Do you think governments have a duty to look at the prices for drugs that we're considering paying for? If we do, how would we approach that? What would be the best way to approach it? If the CDR isn't working, what would be the way to do it? Does anybody have any suggestions on how and who should determine which drugs government should be reimbursing?
Does anybody want to try to answer those basic questions? Louise?